Ophthalmology department, King Chulalongkorn Memorial hospital
Pratumwan, Bangkok, 10330, Thailand
NCT Number: NCT01831206
The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.
Looking for future studies?
Notify Me6 year and older
All sexes
Interventional
Phase 2
Pratumwan, Bangkok, 10330, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collagen cross-linking arm will receive standard medication for corneal ulcer treatment and corneal collagen cross-linking.
Standard treatment arm will receive only standard medication.
Time frame: 1 months
decrement of infiltration size between day0 and day 30
Time frame: 1 months
adverse events after corneal collagen cross-linking (report in descriptive study)
Chulalongkorn University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02570321
Bacterial Ulcer, Corneal Diseases
San Francisco, California, United States
View Trial DetailsNCT06539663
Corneal Diseases, Corneal Injuries
Kuwait City, Kuwait
View Trial DetailsNCT02819232
Infectious Keratitis
Marseille, France
View Trial DetailsNCT04383431
Infectious Keratitis
Sohag, Egypt
View Trial Details